Association of Tryptophan Metabolites with Cognitive Impairment in Chronic Kidney Disease

Clicks: 1
ID: 317632
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #116 of 128 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 128 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background CKD leads to the accumulation of uremic toxins (UTs), including tryptophan-derived metabolites such as kynurenine (KYN), indoxyl sulfate (IS), and indole-3-acetic acid (IAA). IS has been identified as a potential contributor to cognitive impairment (CI), whereas less is known about the other tryptophan metabolites. We aimed to evaluate the association between these toxins related to tryptophan metabolism and CI in patients with CKD. Methods 3033 patients with CKD stages 2 to 5 enrolled in CKD–Renal Epidemiology and Information Network (CKD-REIN) cohort. Patients with both UT measurement and cognitive function screening (with mini-mental state examination (MMSE)) were included. CI was defined as an MMSE score ≤ 26/30. Logistic regression was used to assess the association between the studied UTs and MMSE. Results Of the 2389 included patients (mean (SD) age: 66.5 (12.8) years, 66% males, mean (SD) estimated glomerular filtration rate (eGFR) 34.8 (13.4) ml/min/1.73m2), 858 patients (35.9%) had an MMSE score ≤ 26/30. After adjustment for sociodemographic factors, cardiovascular risk factors, cerebrovascular disease, current depression, eGFR, urinary albumin-to-creatinine ratio, and UTs known to be associated with CI, no significant association was found between KYN or IAA and MMSE ≤ 26/30, whereas IS was significantly associated (Odds Ratio [OR], 95% confidence interval: 1.11 [1.00-1.21]). Conclusion Among tryptophan-derived metabolites studied, IS was associated with CI in patients with CKD, in contrast to KYN and IAA. Despite sharing a common origin, the UTs studied follow distinct metabolic pathways with different effects, highlighting the need for further investigation of the tryptophan pathway on CI in CKD.
Reference Key
openalex_W7165042978 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Gaye Hafez, Ziad A. Massy, Jean‐Claude Alvarez, Marion Pépin, Solène M. Laville, Natália Alencar de Pinho, Islam Amine Larabi, Sophie Liabeuf, Hélène Levassort
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag199
URL
https://doi.org/10.1093/ckj/sfag199
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.